Design Therapeutics Inc (DSGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,264 | -13,265 | -35,533 | -24,468 | -13,150 |
| Depreciation Amortization | 135 | 101 | 52 | -56 | -112 |
| Other Working Capital | 786 | -1,037 | 1,396 | 1,236 | -614 |
| Other Operating Activity | 5,016 | 2,374 | 4,708 | 3,138 | 1,890 |
| Operating Cash Flow | $-22,327 | $-11,827 | $-29,377 | $-20,150 | $-11,986 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -156,261 | 490 | -52,106 | -2,401 | 1,673 |
| PPE Investments | -281 | -76 | -1,538 | -1,184 | -216 |
| Investing Cash Flow | $-156,542 | $414 | $-53,644 | $-3,585 | $1,457 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 381 | 156 | 254,499 | 254,306 | 254,276 |
| Other Financing Activity | -427 | 0 | 124,712 | 124,712 | 124,712 |
| Financing Cash Flow | $-46 | $156 | $379,211 | $379,018 | $378,988 |
| Beginning Cash Position | 298,569 | 298,569 | 2,379 | 2,379 | 2,379 |
| End Cash Position | 119,654 | 287,312 | 298,569 | 357,662 | 370,838 |
| Net Cash Flow | $-178,915 | $-11,257 | $296,190 | $355,283 | $368,459 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,327 | -11,827 | -29,377 | -20,150 | -11,986 |
| Capital Expenditure | -320 | -76 | -1,538 | -1,184 | -216 |
| Free Cash Flow | -22,647 | -11,903 | -30,915 | -21,334 | -12,202 |